Comparative Study of Polymer-Grafted BaTiO3 Nanoparticles Synthesized Using Normal ATRP as Well as ATRP and ARGET-ATRP with Sacrificial Initiator with a Focus on Controlling the Polymer Graft Density and Molecular Weight
Molecules · 2023
DOI: 10.3390/molecules28114444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ikeoluwa E Apata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Howard University, Washington, DC 20059, USA. Hauptthemen laut MEDLINE: Polymers, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Structurally well-defined polymer-grafted nanoparticle hybrids are highly sought after for a variety of applications, such as antifouling, mechanical reinforcement, separations, and sensing. Herein, we report the synthesis of poly(methyl methacrylate) grafted- and poly(styrene) grafted-BaTiO3 nanoparticles using activator regeneration via electron transfer (ARGET ATRP) with a sacrificial initiator, atom transfer radical polymerization (normal ATRP), and ATRP with sacrificial initiator, to understand the role of the polymerization procedure in influencing the structure of nanoparticle hybrids. Irrespective of the polymerization procedure adopted for the synthesis of nanoparticle hybrids, we noticed PS grafted on the nanoparticles showed moderation in molecular weight and graft density (ranging from 30,400 to 83,900 g/mol and 0.122 to 0.067 chain/nm2) compared to PMMA-grafted nanoparticles (ranging from 44,620 to 230,000 g/mol and 0.071 to 0.015 chain/nm2). Reducing the polymerization time during ATRP has a significant impact on the molecular weight of polymer brushes grafted on the nanoparticles. PMMA-grafted nanoparticles synthesized using ATRP had lower graft density and considerably higher molecular weight compared to PS-grafted nanoparticles. However, the addition of a sacrificial initiator during ATRP resulted in moderation of the molecular weight and graft density of PMMA-grafted nanoparticles. The use of a sacrificial initiator along with ARGET offered the best control in achieving lower molecular weight and narrow dispersity for both PS (37,870 g/mol and PDI of 1.259) and PMMA (44,620 g/mol and PDI of 1.263) nanoparticle hybrid systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Howard University, Washington, DC 20059, USA.
- Department of Chemistry, Physics and Atmospheric Science, Jackson State University, Jackson, MS 39217, USA.
- Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204, USA.
ORCID-Profile: Ikeoluwa E Apata, Bhausaheb V Tawade
Förderung
- National Science Foundation
Zitieren
APA
Apata, I. E., Tawade, B. V., Cummings, S. P., Pradhan, N., Karim, A., & Raghavan, D. (2023). Comparative Study of Polymer-Grafted BaTiO3 Nanoparticles Synthesized Using Normal ATRP as Well as ATRP and ARGET-ATRP with Sacrificial Initiator with a Focus on Controlling the Polymer Graft Density and Molecular Weight. Molecules. https://doi.org/10.3390/molecules28114444
Vancouver
Apata IE, Tawade BV, Cummings SP, Pradhan N, Karim A, Raghavan D. Comparative Study of Polymer-Grafted BaTiO3 Nanoparticles Synthesized Using Normal ATRP as Well as ATRP and ARGET-ATRP with Sacrificial Initiator with a Focus on Controlling the Polymer Graft Density and Molecular Weight. Molecules. 2023. doi:10.3390/molecules28114444
BibTeX
@article{Apata2023,
author = {Apata, Ikeoluwa E and Tawade, Bhausaheb V and Cummings, Steven P and Pradhan, Nihar and Karim, Alamgir and Raghavan, Dharmaraj},
title = {Comparative Study of Polymer-Grafted BaTiO3 Nanoparticles Synthesized Using Normal ATRP as Well as ATRP and ARGET-ATRP with Sacrificial Initiator with a Focus on Controlling the Polymer Graft Density and Molecular Weight},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28114444}
}
EUVIMED